A carregar...
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-induced Colon Cancer in F344 Rat Model
Recent observational studies suggest that bisphosphonates (BPs) and anti-diabetes drugs are associated with colorectal cancer (CRC) risk reduction. Hence, we evaluated the CRC preventive effects of BPs (Zometa; Zom; and Fosamax; Fos), individually and when combined with metformin (Met), in azoxymeth...
Na minha lista:
| Publicado no: | Cancer Prev Res (Phila) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7007371/ https://ncbi.nlm.nih.gov/pubmed/31699708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-19-0265 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|